A Retrospective Study of Progression-Free and Overall Survival in Pediatric Medulloblastoma Based on Molecular Subgroup Classification: A Single-Institution Experience-Reference-Cited by-同舟云学术

A Retrospective Study of Progression-Free and Overall Survival in Pediatric Medulloblastoma Based on Molecular Subgroup Classification: A Single-Institution Experience

Published:2017-05-12 Issue: Volume:8 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Jiang Tao,Zhang Yuqi,Wang Junmei,Du Jiang,Raynald ,Qiu Xiaoguang,Wang Ying,Li Chunde

Publisher

Frontiers Media SA

Subject

Neurology (clinical),Neurology

Reference23 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010;Ostrom;Neuro Oncol,2013

2. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus;Ramaswamy;Acta Neuropathol,2016

3. Molecular subgroups of medulloblastoma: the current consensus;Taylor;Acta Neuropathol,2012

4. Molecular subgroups of adult medulloblastoma: a long-term single-institution study;Zhao;Neuro Oncol,2016

5. Impact of tumor location and fourth ventricle infiltration in medulloblastoma;Jiang;Acta Neurochir,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Markers as Predictors for Response to Treatment and Possible Therapeutic Targets in Medulloblastoma;CNS & Neurological Disorders - Drug Targets;2023-06

2. Clinicomorphological and molecular analysis of medulloblastoma and association with survival: A single tertiary care center experience;Journal of Cancer Research and Therapeutics;2023

3. Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country;JCO Global Oncology;2021-09

4. Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery;International Journal of Molecular Sciences;2021-05-06

5. Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups;Journal of the Egyptian National Cancer Institute;2021-02-08